Prevalence of and outcomes associated with corticosteroid prescription in inflammatory bowel disease.

@article{Targownik2014PrevalenceOA,
  title={Prevalence of and outcomes associated with corticosteroid prescription in inflammatory bowel disease.},
  author={L E Targownik and Z. Nugent and Harminder Singh and Charles N Bernstein},
  journal={Inflammatory bowel diseases},
  year={2014},
  volume={20 4},
  pages={622-30}
}
BACKGROUND Corticosteroids are widely used in the management of inflammatory bowel disease (IBD) and are associated with significant side effects. The real world effectiveness of newer drug therapies at reducing corticosteroid use is yet to be reported. The overall burden of corticosteroid use is poorly characterized. METHODS We used a population-based IBD database to evaluate the overall prevalence of corticosteroid exposure, corticosteroid-free survival, and heavy corticosteroid use (≥3000… CONTINUE READING